Scientific work

Prof. Dr. Ahmet Omma

304 publications. The source of the information is stated next to each publication.

Back to profile

  1. Diagnostic Yield of Internal Medicine Referrals to Rheumatology: A Retrospective Single-Center Study

    Medicina, 2026

    DOI 10.3390/medicina62101943 PMID 42942472 Open-access full textSource: ORCID

  2. Plasma Lipidomic Remodeling in Behçet’s Disease Reveals Alterations Associated with Vascular Involvement

    Metabolites, 2026

    DOI 10.3390/metabo16060363 PMID 42346343 1 citation (Europe PMC) Open-access full textSource: ORCID

  3. Can baseline features predict progression to defined connective tissue disease? Insights from a minimum 5-year follow-up study of 504 patients with undifferentiated connective tissue disease: A retrospective study

    Modern rheumatology, 2026

    DOI 10.1093/mr/roag006 PMID 41670330 Source: Europe PMC

  4. Does vascular involvement affect erectile dysfunction in patients with Behçet's disease?: a single-center cross-sectional study

    Sao Paulo medical journal = Revista paulista de medicina, 2026

    DOI 10.1590/1516-3180.2025.3295.12062026 PMID 42788553 Open-access full textSource: Europe PMC

  5. Do different organ involvements cause different comorbidity profiles in Behçet's syndrome?

    Postgraduate medicine, 2026

    DOI 10.1080/00325481.2026.2641859 PMID 41797226 Source: Europe PMC

  6. Non-pulmonary arterial involvement in Behçet's disease: a multicenter retrospective case series

    Turkish journal of medical sciences, 2026

    DOI 10.55730/1300-0144.6206 PMID 42499446 Open-access full textSource: Europe PMC

  7. Screening of osteoporosis in patients with ANCA-associated vasculitis (AAV) is quite low: results from a country-wide study

    Internal and emergency medicine, 2026

    DOI 10.1007/s11739-026-04349-3 PMID 41946942 Open-access full textSource: Europe PMC

  8. Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicentre observational study

    Rheumatology, 2026

    DOI 10.1093/rheumatology/keag107 PMID 41734284 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  9. The 2025 Turkish Society for Rheumatology management recommendations for ANCA-associated vasculitides

    Ulusal Romatoloji Dergisi, 2026

    DOI 10.4274/raed.galenos.2025.70883 Open-access full textSource: OpenAlex

  10. Predictors of Cyclophosphamide Resistance in Granulomatosis with Polyangiitis: A Retrospective Cohort Study

    Mediterranean Journal of Rheumatology, 2026

    DOI 10.31138/mjr.150736.pcr PMID 42100069 Open-access full textSource: OpenAlex

  11. Real-world experience of rituximab therapy in ANCA-associated vasculitis according to renal involvement

    Ulusal Romatoloji Dergisi, 2026

    DOI 10.4274/raed.galenos.2026.49368 Open-access full textSource: OpenAlex

  12. Serum calprotectin as a biomarker for large vessel vasculitis: a multicenter cross-sectional study

    International Immunopharmacology, 2026

    DOI 10.1016/j.intimp.2026.117205 PMID 42541830 Source: OpenAlex

  13. The effect of pulmonary nodule presence on disease severity and course in ANCA-associated vasculitis: a multicenter cohort study

    BMC Pulmonary Medicine, 2026

    DOI 10.1186/s12890-026-04625-0 Open-access full textSource: OpenAlex

  14. The role of neopterin in rheumatoid arthritis-related dry eye

    European Journal of Ophthalmology, 2026

    DOI 10.1177/11206721261491820 PMID 42782109 Source: OpenAlex

  15. Adjunctive Acupuncture For Sjögren-Related Dry Eye: A Prospective Sham-Controlled Study

    ESCRS Abstracts, 2026

    DOI 10.82333/nw1x-9d90 Open-access full textSource: OpenAlex

  16. Venous Thromboembolism May Be Increased in the Early Phases of ANCA ‐Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR ‐ VaS Experience

    International Journal of Rheumatic Diseases, 2025

    DOI 10.1111/1756-185x.70506 PMID 41408677 Source: OpenAlex

  17. Turkish Society for Rheumatology guideline for the management of ANCA-associated vasculitides

    Ulusal Romatoloji Dergisi, 2025

    DOI 10.4274/raed.galenos.2025.26349 Open-access full textSource: OpenAlex

  18. Medication adherence and real-world factors of first line induction treatment selection in ANCA-associated vasculitis

    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2025

    DOI 10.36141/svdld.v42i3.16880 PMID 41026025 Open-access full textSource: Europe PMC

  19. Novel inflammatory biomarkers for discriminating vascular involvement in Behçet's syndrome: evaluating SII, SIRI, and NPAR

    Biomarkers in medicine, 2025

    DOI 10.1080/17520363.2025.2473312 PMID 40024670 5 citations (Europe PMC) Open-access full textSource: Europe PMC

  20. Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients

    Wiener klinische Wochenschrift, 2025

    DOI 10.1007/s00508-024-02424-3 PMID 39259223 2 citations (Europe PMC) Source: Europe PMC

  21. Prognostic significance and rationality of regular non-invasive imaging follow-up in Takayasu arteritis: A large multicenter cohort study

    Seminars in Arthritis and Rheumatism, 2025

    DOI 10.1016/j.semarthrit.2025.152813 PMID 40854262 3 citations (OpenAlex) Source: OpenAlex

  22. Genetic susceptibility and validation of angiographic patterns in Takayasu arteritis

    Journal of Autoimmunity, 2025

    DOI 10.1016/j.jaut.2025.103496 PMID 41207179 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  23. Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

    Reumatismo, 2025

    DOI 10.4081/reumatismo.2025.1792 PMID 40586484 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  24. Long-term outcomes of aortic valve insufficiency in patients with Takayasu arteritis

    Frontiers in Immunology, 2025

    DOI 10.3389/fimmu.2025.1667603 PMID 41058700 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  25. Comorbidity Profile of Familial Mediterranean Fever Patients Varies by Treatments

    Hitit Medical Journal, 2025

    DOI 10.52827/hititmedj.1582847 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  26. The Role of Prognostic Nutritional Index in Vascular Behçet’s Syndrome

    Medical Records, 2025

    DOI 10.37990/medr.1593728 Open-access full textSource: OpenAlex

  27. COVID-19 or systemic lupus erythematosus: Attention to similarity

    Revista română de medicină de laborator, 2025

    DOI 10.2478/rrlm-2025-0002 Open-access full textSource: OpenAlex

  28. Evaluation of digestive symptoms in patients with systemic sclerosis: A cross-sectional study

    Medicine Science | International Medical Journal, 2025

    DOI 10.5455/medscience.2024.12.156 Open-access full textSource: OpenAlex

  29. The role of thiol-disulfide homeostasis in gouty arthropathy

    Ulusal Romatoloji Dergisi, 2025

    DOI 10.4274/raed.galenos.2025.61687 Open-access full textSource: OpenAlex

  30. Serum Semaphorin 3A Levels in Patients with Behçet’s Disease with and without Vascular Involvement

    Bratislavské lekárske listy/Bratislava medical journal, 2025

    DOI 10.1007/s44411-025-00084-x Open-access full textSource: OpenAlex

  31. ABS1137 SCHEDULES AND SURVIVAL OF RITUXIMAB IN PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS: A MULTI-CENTER, REAL-WORLD EXPERIENCE

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.2087 Open-access full textSource: OpenAlex

  32. ABS0104 Biological treatment may be an option as first steroid-sparing agent in a subgroup of young Takayasu Arteritis patients with prominent acute phase reactants and constitutional symptoms

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.2016 Open-access full textSource: OpenAlex

  33. POS0953 VASCULAR DAMAGE IS LESS PRESENT IN AN EARLY INCEPTION COHORT IN TAKAYASU'S ARTERITIS

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.308 Open-access full textSource: OpenAlex

  34. Seasonal variation in incidence and relapse of granulomatosis with polyangiitis: A retrospective cohort study from Central Anatolia.

    Sarcoidosis vasculitis and diffuse lung diseases, 2025

    DOI 10.36141/svdld.v42i2.16537 PMID 40699500 Open-access full textSource: OpenAlex

  35. What are the Anti-Rheumatic Drug Prescribing Patterns in Rheumatoid Arthritis Patients With Chronic Kidney Disease?: A Single-Center Cross-Sectional Study

    Medical Records, 2025

    DOI 10.37990/medr.1729553 Open-access full textSource: OpenAlex

  36. General Characteristics of Rheumatology Consultations in the Emergency Department: Retrospective Results of a Tertiary Hospital

    Archives of Current Medical Research, 2025

    DOI 10.47482/acmr.1659275 Open-access full textSource: OpenAlex

  37. VASCULAR DAMAGE IS LESS PRESENT IN AN EARLY INCEPTION COHORT IN TAKAYASU’S ARTERITIS

    Kocaeli Üniversitesi - AVESİS, 2025

    Source: OpenAlex

  38. Takayasu arteritinde aspirin ve statin kullanımı hastalık prognozunu değiştirebilir mi?

    Kocaeli Üniversitesi - AVESİS, 2025

    Source: OpenAlex

  39. Lupus nefriti klinik ve laboratuvar göstergelerinin incelenmesi: tek merkez deneyimi

    AYBU AVESIS, 2025

    Source: OpenAlex

  40. Biological treatment may be an option as first steroid-sparing agent in a subgroup of young Takayasu Arteritis patients with prominent acute phase reactants and constitutional symptoms

    Kocaeli Üniversitesi - AVESİS, 2025

    Source: OpenAlex

  41. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

    Internal and Emergency Medicine, 2024

    DOI 10.1007/s11739-024-03577-9 PMID 38553624 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  42. POS0218 VENOUS THROMBOEMBOLISM IN ANCA-ASSOCIATED VASCULITIS MIGHT BE ASSOCIATED WITH DISEASE ACTIVITY: RESULTS OF TR-VaS COHORT

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.2661 Source: OpenAlex

  43. Role of serum calprotectin in identifying familial Mediterranean fever attacks

    Irish journal of medical science, 2024

    DOI 10.1007/s11845-024-03659-9 PMID 38478181 2 citations (Europe PMC) Source: Europe PMC

  44. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies

    Rheumatology international, 2024

    DOI 10.1007/s00296-024-05708-z PMID 39245763 1 citation (Europe PMC) Source: Europe PMC

  45. Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis

    Archives of rheumatology, 2024

    DOI 10.46497/archrheumatol.2023.10183 PMID 38774706 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  46. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients

    Turkish journal of medical sciences, 2024

    DOI 10.55730/1300-0144.5768 PMID 38812619 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  47. Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis

    Seminars in Arthritis and Rheumatism, 2024

    DOI 10.1016/j.semarthrit.2024.152446 PMID 38669786 15 citations (OpenAlex) Source: OpenAlex

  48. Frequency and the effects of spondyloarthritis-spectrum disorders on the clinical course and management of Takayasu arteritis: an observational retrospective study

    Clinical Rheumatology, 2024

    DOI 10.1007/s10067-024-06939-y PMID 38563865 8 citations (OpenAlex) Open-access full textSource: OpenAlex

  49. Interstitial Lung Disease in Primary Sjögren's Syndrome: Risk factors for occurrence and radiographic progression.

    Sarcoidosis vasculitis and diffuse lung diseases, 2024

    DOI 10.36141/svdld.v41i3.15548 PMID 39315979 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  50. The burden of face affected questionnaire in patients with systemic sclerosis: Translation, cross-cultural adaptation and psychometric properties in the Turkish version

    The Egyptian Rheumatologist, 2024

    DOI 10.1016/j.ejr.2024.01.002 1 citation (OpenAlex) Source: OpenAlex